ABSTRACT Addition of cGMP to cytosol of human endometrium or to cells of the endometrial cancer line HEC-1 produced severalfold increases in specific estrogen binding (EB) levels. This effect was maximal with 1 1AM cGMP in the presence of 0.1 mM isobutylmethyixanthine (a phosphodiesterase inhibitor) during incubations with [3H]estradiol. In contrast, cAMP decreased EB levels under similar conditions. The effects of cyclic nucleotides on EB levels were complete in <15 min in the presence of Mg2+, Mn2 , or Ca2 . The EB sites generated b~y the addition of cGMP during labeling of cytosol with 10 nM [ H]estradiol were found to sediment in the 8S and 4S regions of low-salt glycerol gradients. No changes in EB levels were observed when cyclic nucleotides were added to cytosol depleted of ATP by preincubation at 4°C for 3 hr, but responsiveness was restored by addition of exogenous ATP. The ATP requirement and the pattern of dependence of cyclic nucleotide actions on divalent cation concentrations suggest that cGMP and cAMP effects may be mediated by kinases and may involve phosphorylations. Another possibility is that the cyclic nucleotides interact allosterically with the binder in the presence of ATP. Addition of sodium molybdate, ATP, and GTP to homogenates of endometrial tissue or HEC-1 cells produces increases in EB levels similar to those obtained by the addition of cGMP. However, these compounds are much less active when added to cytoplasm or cytosol. On the basis of these and other observations, it is hypothesized that molybdate, ATP, and GTP affect EB levels primarily by increasing cGMP concentrations through processes involving a plasma membrane-bound guanylate cyclase.
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We previously reported that the addition of cGMP to homogenates of normal human endometrium or endometrial adenocarcinoma cells produced severalfold increases in the levels of specific estradiol (E2) binders sedimenting in the 8S and 4S region of low-salt glycerol gradients. Addition of sodium molybdate to intact or homogenized endometrial cells or endometrial tissue caused a similar elevation in specific estrogen binding (EB) levels which could not be explained by stabilization of E2 binders after cell disruption, a mechanism usually proposed to account for molybdate effects on steroid binding. Addition of ATP or GTP to the homogenates also increased specific E2 binding levels, whereas cAMP was found to decrease binding and to counteract the effects of cGMP, molybdate, GTP, and ATP (1) .
These results, together with earlier findings of rapid fluctuations in the concentration of E2 binders in vivo (2, 3) , suggested that binding sites might be subject to reversible modification by mechanisms similar to the phosphorylation/dephosphorylation reactions implicated in the regulation of glucocorticoid (4, 5) and progesterone binding (6 The publication costs ofthis article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Proc. Nati. Acad. Sci. USA 80 (1983) 2487 Radioactivity in 100-sud aliquots of the supernatant was measured by liquid scintillation spectrometry. The counts were normalized to the amount of protein present in each tube, and specific binding was calculated from the difference between counts in tubes with and without DES.
Glycerol Density Gradient Analysis. Continuous 16-41% glycerol gradients (total, 3.4 ml) were prepared in 10 mM Tris, pH 8.0/12 mM thioglycerol/1.5 mM EDTA (TTE buffer) containing 50 mM KC1. Aliquots of cytosol containing labeled E2 binders and diluted with an equal volume of TTE buffer were layered on the top of the gradient and centrifuged at 40C for 22 hr at 105,000 X g. The bottom of the tube was pierced and 100-,ul fractions were collected and assayed for radioactivity.
Five marker proteins-alcohol dehydrogenase (7.8 S), bovine serum albumin (4.6 S), ovalbumin (3.5 S), Hb (3.0 S), and horse heart cytochrome (2.2 S)-were layered on a separate gradient and run in parallel. Location of the marker proteins was determined by protein assay. Linear regression analysis of relative mobility vs. sedimentation coefficient of the markers was performed for each experiment; correlation coefficients were consistently >0.97.
ATP Measurements. Cellular ATP concentrations were determined according to the method of Stanley and Williams (8) as modified by Guffanti et aL (9) . ATP was extracted from cell homogenates with 30% perchloric acid and the extract was neutralized with 1 M KOH. Aliquots of the supernatant were assayed by the firefly luciferase method. Initial rates of light flashes were measured in a Beckman LS-230 spectrometer for 6-sec intervals with the coincidence switch off, using a voltage window adequate for 3H measurements. Assays were done in a phosphate/arsenate pH 7.4 buffer containing 0.1 M KH2PO4, 0.1 M arsenate, 40 mM Mg2SO4, and 40 mM MgCl2. The GMTD buffer used for the steroid binding assay was used as a control in each experiment to ensure that there was no chemical interference by any component in the buffer. Rates corresponding to ATP standard were determined for each experiment with the sodium salt of ATP and a fresh firefly lantern extract (Sigma). The assay was linear over the range 1-100 nM ATP.
Protein Assay. Concentration of protein in cytosol preparations from fresh human endometrium or HEC-1 cells and solutions of internal markers for gradient centrifugations were determined with a Bio-Rad protein assay kit based on the colorimetric method of Bradford (10) . RESULTS cGMP at 1 mM, but not 20 mM Na2MoO4, 1 mM ATP, or 1 mM GTP, increased EB levels when added to cytoplasm prepared by low-speed centrifugation or to cytosol prepared by high-speed centrifugation (of secretory tissue homogenates) during labeling with 80 nM [3H]E2 with or without 8 ,uM DES at 4°C (Fig.   1 ). Addition of any of these compounds to the corresponding cell homogenate produced 2-to 7-fold increases in specific
[3H]E2 binding (1) . Similar increments relative to basal EB levels, which vary from culture to culture and specimen to specimen as previously reported (2, 3, 11) , were obtained with several cultures of HEC-1 cells and specimens of endometrial adenocarcinoma (four experiments). The slight effect of ATP or GTP added to cytosol or cytoplasm in the experiment shown in Fig. 1 and in some of the other experiments does not appear to be significant and was always less than 10% of the effect observed when these compounds were added to homogenates.
These observations confirm and extend our previous findings (1) by molybdate when whole cells or homogenates are labeled with [3H]E2 at 0-40C. This effect is different from the known protective or stabilizing action of molybdate added to cytosol under conditions that otherwise result in a loss of E2 receptorse.g., temperatures >150C or the long periods (>12 hr in buffer solution) required for gradient centrifugation analysis.
It is shown in Fig. 1 that the generation of binding sites by ATP and GTP also requires factors that sediment during lowspeed centrifugation. In contrast, cGMP can exert a stimulatory action on EB directly when added to cytosol. cAMP, originally found to lower EB levels in homogenates of endometrial tissue and HEC-1 cells (1), is also capable of affecting EB when added to cytosol of HEC-1 cells (Fig. 2) . The effects of cGMP and cAMP on EB levels were concentration-dependent. In the presence of 0.1 mM isobutylmethylxanthine (iBuMeXan), a phosphodiesterase inhibitor, effects of cyclic nucleotides on specific estrogen binding were noted at 1 nM and became maximal at about 1 pM.
Both the activation* and inactivation of E2 binding sites required divalent cations but the reactions differed with regard to optimal cation concentration (Fig. 3) . The extent of activation in response to 1 ,uM cGMP continued to increase as the concentration of Mg2+ or Mn2+ was increased up to 100 mM. In contrast, inactivation of estrogen binding in response to 1 ,uM cAMP was maximal at 2-5 mM Mg2+ or Mn2' and declined at greater concentrations of these cations. (Fig. 4) HEC-1 cells were homogenized as in Fig. 1 but without Mg9l2 in the GMTD buffer used for homogenization. Cytosol was prepared and labeled in the presence of cGMP (Upper) or cAMP (Lower) and increasing concentrations of MgCl2 (x), MnCl2 (o), or CaC12 (.). Labeling and measurement of EB levels were carried out as in Fig. 1 . The averages of duplicate assays in a single experiment are shown, and these data are representative of results obtained in three similar experiments. In one of those experiments, low EB levels in the control prevented the evaluation of cAMP effects. EB levels achieved during these incubations and during a 90-min period in the absence of cyclic nucleotides were determined as in Fig. 1 (Fig.  6) . The levels of ATP in cytosol of HEC-1 cells immediately after preparation was 3 nmol/mg of protein, and addition of cGMP or cAMP produced changes in EB levels similar to those shown in Fig. 2 The remainder of the homogenate was kept at 40C for 3 hr to allow for ATP concentrations to decline to undetectable levels and then was incubated as described for the fresh homogenate, with or without the addition of exogenous ATP. Concentrations ofATP were measured by the luciferin-luciferase method after extraction of the homogenates with 30% HC104 and neutralization with 1 M KOH. EB levels were determined as in Fig. 1 cytosol to obtain 25 nmol/mg of protein, the responsiveness to cGMP and cAMP was restored and the EB levels obtained were approximately the same as those observed when the cyclic nucleotides were added to the original cytosol.
Estrogen binding sites sedimenting in the 4S and 8S regions of a low-salt glycerol gradient could be increased by cGMP (Fig.  7) . These results were obtained by incubating cytosol from HEC-1 cells with 10 nM [3H]E2 in the presence or absence of 1 gM cGMP and 0.1 mM iBuMeXan. The amount of specifically bound radioactivity in each of these two regions was approximately doubled in cGMP-treated cytosol compared to untreated controls.
DISCUSSION
The results reported here demonstrate that cGMP and cAMP can directly affect cytosolic E2 binding, whereas GTP, ATP, and MoO4 increase EB levels indirectly, perhaps by increasing cGMP concentrations through processes involving a membrane-bound guanylate cyclase (1) .
Characterization of the cGMP-dependent generation or activation and the cAMP-dependent inactivation of estrogen binders indicates that the mechanisms involved in these two processes may be similar. Both activation and inactivation require ATP and either Mg2+ or Mn2+ for maximal effects. Both reactions show similar dependence or concentrations of the respective cyclic nucleotides and are rapidly completed, even at 40C.
The observation that ATP and divalent cations are required for optimal cGMP-related increases in E2 binders suggests that activation might involve phosphorylations, as has been suggested for the glucocorticoid receptors (4, 5 As shown by the data in Fig. 6 , intracellular concentrations of ATP appear to be sufficient to support a full effect of cGMP. It therefore is likely that much of the increase in EB levels induced by the addition of ATP to homogenates is due to generation of cGMP through an activation of membrane-bound guanylate cyclase (15) . It is possible, however, that some specimens depleted of ATP during prolonged periods of hypoxia before analysis may show an enhancing effect of ATP even when it is added directly to cytosol.
The low levels at which cGMP and cAMP exert significant effects on EB levels [e.g., 1 nM in the presence of iBuMeXan ( Fig. 2) ] point to a possible physiological role for the cyclic nucleotides in the regulation of levels of estrogen binders in vivo. Variations in cGMP and cAMP levels may be responsible for the reported rapid fluctuations in E2 binding levels in cultures of endometrial cells (2) .
The finding that cAMP and cGMP have opposite effects on EB levels is characteristic of the action of these compounds on various other physiological events (16) . It is of particular interest that the concentrations of cGMP and cAMP have been reported to vary in opposite directions during the estrus cycle in mature intact rats; cGMP levels have been shown to be at their highest and cAMP levels at their lowest in proestrus (17) , when the concentration of total uterine estrogen receptors is reported to be maximal (18, 19) .
It has also been reported that dibutyryl cAMP lowers cytoplasmic and nuclear E2 binding in induced rat mammary carcinomas (20) , a result in intact animals that agrees with our observation in cultured cells and endometrial tissues. Finally, melatonin has been shown to increase cytoplasmic E2 receptors in uterine tissue of prepubertal hamsters in vivo and in vitro ( ¶). Our results indicate that this effect may be due to the ability of melatonin to increase cGMP levels (21 The cGMP-induced increase in the concentration of the specific 8S binder labeled with 10 nM [3H]E2 (Fig. 7) suggests that the cyclic nucleotide activates the type of binding usually considered to correspond to the intracellular estrogen receptor as well as a smaller (4S) binder that has been also frequently observed in specimens of endometrial tissue (22) .
